Clinical Trials Browser

Phase EARLY_PHASE1 × abemaciclib × Breast × Clear all

NCT04088032 2020-07-16

Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer

Phase EARLY_PHASE1 Withdrawn

BreastOther neoplasm

Breast Cancer Female